Strain of E. coli may offer protections against its more malevolent cousins

Typically, there aren’t a lot of positive thoughts when E. coli, generally found in animal and human intestines, is mentioned. It’s been blamed for closing beaches and swimming pools and shuttering restaurants because of contamination in salad bars, meats or other food items.

But for more than a century, one strain of the bacteria, E. coli Nissle 1917, has been used as a probiotic and therapeutic agent. Currently, it is used in some countries to treat intestinal inflammation.

Now researchers at the University of Cincinnati College of Medicine say E. coli Nissle may also protect human cells against other more pathogenic strains of E. coli such as E. coli 0157:H7, which is commonly associated with contaminated hamburger meat.

Alison Weiss, PhD, professor, and Suman Pradhan, PhD, research associate, both in in the UC Department of Molecular Genetics, Biochemistry and Microbiology, used stem cell-derived human intestinal organoid tissues to evaluate the safety of Nissle and its ability to protect from pathogenic E. coli bacteria 0157:H7.

They found that human intestinal tissues (HIO) were not harmed by the Nissle bacteria introduced into human intestinal organoids while pathogenic E. coli bacteria destroyed the epithelial layer of the HIO. More importantly, Nissle protected the HIOs when added prior to pathogenic E. coli bacterial infection.

The study’s findings are available online in mBio, the scholarly journal of the American Society for Microbiology.

“Nissle did not kill pathogenic E. coli, but rather ramps up your intestinal responses and prepares you for possible pathogens attacking the intestine,” explains Weiss, corresponding author of the study. “We don’t know how it does this, but our study confirms its effectiveness in human cells. Our hope is to figure out how this is happening.”

“There are all sorts of flavors of E. coli,” says Weiss. “They gather genes from all over the place and channel a whole bunch of other pathogens. There are E.coli which can also cause urinary tract infections. What is special is that bad E. coli have a chunk of extra genes that allow them to cause problems. The good E. coli are stripped down of these genes and they don’t have the capacity to do bad things.”

Weiss says they hope to learn more about the abilities of Nissle in order to develop a treatment of E. coli infections that often result from the production of Shiga toxins. The Centers for Disease Control and Prevention estimates that 265,000 such infections occur annually causing stomach cramps, diarrhea and vomiting. Cases can be mild to severe and affect people of all ages, though the illness can be particularly hard on smaller children, who are more likely to die from an infection, says Weiss. Moreover, antibiotic treatment of children with E. coli 0157:H7 infection increases the risk of hemolytic-uremic syndrome.

“Right now there is no cure for an E. coli infection,” says Weiss. “We can give individuals fluids, but it can be really deadly and it would be really nice for us to figure out how to cure it.”

“E. coli is carried asymptotically by all sorts of animals and released into their fecal matter and then leading to possible contamination if it comes into contact with food items or is ingested,” says Weiss. “It is difficult though still possible to screen meat for E. coli. The best possible protection is to cook meat properly before consuming it. E. coli is also found in raw vegetables such as lettuce and it can be difficult to detect and remove.”

The study conducted by Weiss and Pradhan was supported by National Institutes of Health grants U19-AI116491 and R01AI139027 and by the National Institute of Diabetes and Digestive and Kidney Diseases grant P30 DK078392.

Story Source:

Materials provided by University of Cincinnati. Original written by Cedric Ricks. Note: Content may be edited for style and length.

Share Button

Famous ‘Jurassic Park’ dinosaur is less lizard, more bird

From movies to museum exhibits, the dinosaur Dilophosaurus is no stranger to pop culture. Many probably remember it best from the movie “Jurassic Park,” where it’s depicted as a venom-spitting beast with a rattling frill around its neck and two paddle-like crests on its head.

The dinosaur in the movie is mostly imagination, but a new comprehensive analysis of Dilophosaurus fossils is helping to set the record straight. Far from the small lizard-like dinosaur in the movies, the actual Dilophosaurus was the largest land animal of its time, reaching up to 20 feet in length, and it had much in common with modern birds.

The analysis was published open access in the Journal of Paleontology on July 7.

Dilophosaurus lived 183 million years ago during the Early Jurassic. Despite big-screen fame, scientists knew surprisingly little about how the dinosaur looked or fit into the family tree, until now.

“It’s pretty much the best, worst-known dinosaur,” said lead author Adam Marsh. “Until this study, nobody knew what Dilophosaurus looked like or how it evolved.”

Seeking answers to these questions, Marsh conducted an analysis of the five most-complete Dilophosaurus specimens while earning his Ph.D. from The University of Texas at Austin’s Jackson School of Geosciences. He is now the lead paleontologist at Petrified Forest National Park.

The analysis is co-authored by Jackson School Professor Timothy Rowe, who discovered two of the five Dilophosaurus specimens that were studied.

The study adds clarity to a muddled research record that reaches back to the first Dilophosaurus fossil to be discovered, the specimen that set the standard for all following Dilophosaurus discoveries. That fossil was rebuilt with plaster, but the 1954 paper describing the find isn’t clear about what was reconstructed — a fact that makes it difficult to determine how much of the early work was based on the actual fossil record, Marsh said.

Early descriptions characterize the dinosaur as having a fragile crest and weak jaws, a description that influenced the depiction of Dilophosaurus in the “Jurassic Park” book and movie as a svelte dinosaur that subdued its prey with venom.

But Marsh found the opposite. The jawbones show signs of serving as scaffolding for powerful muscles. He also found that some bones were mottled with air pockets, which would have helped reinforce the skeleton, including its dual crest.

“They’re kind of like bubble wrap — the bone is protected and strengthened,” Marsh said.

These air sacs are not unique to Dilophosaurus. Modern birds and the world’s most massive dinosaurs also have bones filled with air. In both cases, the air sacs lighten the load, which helped big dinosaurs manage their bulky bodies and birds take to the skies.

Many birds use the air sacs to perform other functions, from inflating stretchy areas of skin during mating rituals, to creating booming calls and dispersing heat. The intricate array of air pockets and ducts that extend from Dilophosaurus’ sinus cavity into its crests means that the dinosaur may have been able to perform similar feats with its headgear.

All the specimens Marsh examined came from the Kayenta Formation in Arizona and belong to the Navajo Nation. The University of California Museum of Paleontology holds in trust three of the specimens. The Jackson School Museum of Earth History holds the two discovered by Rowe.

“One of the most important responsibilities of our museum is curation,” said Matthew Brown, director of the Vertebrate Paleontology Collections. “We are very excited to help share these iconic Navajo Nation fossils with the world through research and educational outreach, as well as preserve them for future generations.”

To learn more about how the fossils compared with one another, Marsh recorded hundreds of anatomical characteristics of each fossil. He then used an algorithm to see how the specimens compared with the first fossil — which confirmed that they were indeed all Dilophosaurus.

The algorithm also revealed that there’s a significant evolutionary gap between Dilophosaurus and its closest dinosaur relatives, which indicates there are probably many other relatives yet to be discovered.

The revised Dilophosaurus record will help paleontologists better identify specimens going forward. Marsh said that the research is already being put into action. In the midst of his analysis, he discovered that a small braincase in the Jackson School’s collections belonged to a Dilophosaurus.

“We realized that it wasn’t a new type of dinosaur, but a juvenile Dilophosaurus, which is really cool,” Marsh said.

Share Button

Algae species discovered infesting NW Hawaiian waters has been identified

A newly-identified, fast-growing species of algae poses a major threat to coral reefs and the ocean ecosystem. It was previously discovered in Papah?naumoku?kea Marine National Monument by a team of researchers from the University of Hawai?i, Western Australian Herbarium, College of Charleston and National Oceanic and Atmospheric Administration (NOAA).

Newly-named Chondria tumulosa by UH researchers, the alga has no known origin and has been observed smothering entire reefs and the corals, native algae and other organisms that live in one of the northern atolls. It also has a “tumbleweed-like” growth and appears to easily detach and spread.

“I think this is a warning of the kinds of changes that are to come for the northwestern Hawaiian Islands,” said UH Manoa College of Natural Sciences Interim Associate Dean and Professor Alison Sherwood, the lead researcher on the project. “We have, not until now, seen a major issue like this where we have a nuisance species that’s come in and made such profound changes over a short period of time to the reefs.”

It was not widespread when first detected by NOAA divers in 2016 but a 2019 visit to the same area revealed that it is now covering up to several thousand square meters at the Pearl and Hermes Atoll.

“Until we understand whether it is native or introduced, and until we better understand what is driving this outbreak, it is critically important that research divers and research ships do not inadvertently transport this species to other islands,” said Randall Kosaki, NOAA research coordinator at Papah?naumoku?kea Marine National Monument. “Thus, all of our dive gear was soaked in bleach, and all of our dive boats were sprayed down with bleach prior to returning to Honolulu.”

The findings were featured in a PLOS ONE article, “Taxonomic determination of the cryptogenic red alga, Chondria tumulosa sp. nov., (Rhodomelaceae, Rhodophyta) from Papah?naumoku?kea Marine National Monument, Hawai?i, USA: a new species displaying invasive characteristics.”

‘Nuisance’ not ‘invasive’

Although Chondria tumulosa displays invasive characteristics, researchers are calling it a “nuisance alga” because they have not identified it as being introduced from another region.

“The main Hawaiian Islands are impacted by several well-known invasive seaweeds, but reports of nuisance algae in Papah?naumoku?kea Marine National Monument are far fewer, and none have been present at the level of abundance seen in this new alga,” Sherwood said.

Next steps

Researchers will conduct mapping and molecular analyses, and will develop mitigation strategies to assist in the development of appropriate management actions.

“This is a highly destructive seaweed with the potential to overgrow entire reefs,” College of Charleston Assistant Professor Heather Spalding said. “We need to figure out where it’s currently found, and what we can do to manage it. This type of research needs trained divers in the water as quickly as possible. The sooner we can get back to Papah?naumoku?kea Marine National Monument, the better.”

Story Source:

Materials provided by University of Hawaii at Manoa. Note: Content may be edited for style and length.

Share Button

Cumberlege review: The patients who fought for answers

The way patients’ concerns over side effects were dealt with is addressed in a long-awaited review.

Share Button

Health24.com | Milk chocolate, dairy and fatty foods tied to acne in adults

  • The reason for acne in adulthood is most likely related to what you eat
  • A typical Western diet can increase one’s chances of getting pimples
  • Foods like vegetables, fish and more plant-based fare are tied to reductions in acne for adults

Are you plagued by acne even though you’re way past puberty? A new report might have you avoiding certain foods.

The study of more than 24 000 French adults found that sweet and greasy fare – especially milk chocolate, sweetened drinks, dairy products, and sugary or fatty foods – all appeared to raise the odds for zits.

The new findings “appear to support the hypothesis that the Western diet (rich in animal products and fatty and sugary foods) is associated with the presence of acne in adulthood”, said the team led by dermatologist Dr Emilie Sbidian, of Mondor Hospital in Paris.

Food affects hormones

One US dermatologist who read over the report wasn’t surprised.

“This new study confirms what I have always believed, that proper nutrition is an important component of acne treatment,” said Dr Michele Green, of Lenox Hill Hospital in New York City.

The likely culprit? Foods’ effects on hormones, she said.

“One of the reasons that this high ‘glycemic’ diet – high in sugar – causes acne, is that it changes the normal dynamic of one’s hormones,” Green explained. “These high-sugar diets can cause a rise in insulin levels and this affects other hormones, which lead to the development of acne.”

Adding to that, Green said, “there are also ongoing studies looking into the hormones that cows are fed in their feed, which may also have an effect on the development of acne.”

The new study focused on acne in adults, not on people younger than 18 years of age. Unlike many prior studies, this one was especially rigorous. Thousands of French participants filled out researcher-validated 24-hour dietary records over a two-week period. In these food diaries, participants recorded all foods and drinks consumed, and at what amounts.

Quantity matters

They also recorded any incidence of an acne outbreak.

The result: After adjusting for a number of confounding factors, certain foods – dairy, fatty and sugary fare – emerged as potential acne triggers.

Quantity mattered. For example, having one glass of milk per day bumped up the odds of an outbreak by 12%, and a glass of a sugary drink (such as soda) raised it by 18%.

But drink five glasses of either a sugary drink or milk in a day, and your odds of developing zits rose by more than twofold or 76%, respectively.

Fatty foods appeared to do people’s skin no favours, either: One portion of a fatty (think French fries, burgers) food or a sugary treat (sugared donuts, cookies) boosted the odds for an outbreak by 54%, the study found.

And “a complete meal of fatty and sugary products” upped the odds more than eightfold, Sbidian’s group reported.

More than a cosmetic nuisance

Overall, “adults with current acne were found to be less likely to have a healthy dietary pattern,” the French team concluded.

And what about chocolate? Intake of milk chocolate did seem tied to acne risk, bumping up the odds for an outbreak by 28%, the researchers found. But consumption of less fatty dark chocolate was actually tied to a 10% lower odds for acne.

Healthier foods – such as vegetables, fish and more plant-based fare – were also tied to reductions in acne for adults, the findings showed.

For many, acne isn’t just a cosmetic nuisance, Green noted.

“Acne patients suffer from low self-esteem and depression, and many go on to have physical acne scars, which they carry on their face for a lifetime,” she said.

In fact, “acne is an extremely important and emotional issue that frequently gets neglected,” Green added.

“More studies need to be done but it is so important to investigate the role of diet, nutrition and chemicals, and their effect on blood hormonal levels, acne, and our health in general,” she said.

The study was published online on 10 June in JAMA Dermatology.

Image credit: iStock

NEXT ON HEALTH24X

Share Button

Health24.com | An HIV drug you only take twice a year?

  • Longer-acting HIV medications could free people from taking daily pills
  • An experimental drug is now able to maintain active levels in the blood of patients for more than six months
  • Scientists are, however, still working on ways to potentially cure HIV/Aids

Scientists are reporting an early step toward an HIV drug that could potentially be taken only a couple of times per year.

A single injection of the experimental drug, called lenacapavir, was able to lower blood levels of HIV in a small group of patients. And it was capable of maintaining active levels in the blood for more than six months.

It all raises the possibility of one day having an HIV treatment that only needs to be taken twice a year.

The current treatment regimens for HIV – combinations of oral drugs often called “cocktails” – generally work quite well, said study co-author Dr Martin Rhee.

No more daily pills

“But patients often say that over time, taking daily pills can be a burden,” said Rhee, director of clinical research for Gilead Sciences, Inc. – which is developing lenacapavir.

So the hope is that longer-acting HIV medications could “free people from daily pills,” Rhee said.

Beyond that, he noted, longer-acting drugs could potentially offer a simpler way to prevent HIV in high-risk people: Right now, that’s done with a daily pill regimen known as PrEP (pre-exposure prophylaxis).

However, much more work remains ahead. The new study, published on 1 July  in the journal Nature, offers a “proof of principle” that a dosing interval of every six months is possible, Rhee said.

The researchers found that in 40 healthy people, lenacapavir appeared safe and could remain active in the body for more than six months. And in 32 people with previously untreated HIV, a single injection reduced viral levels in the blood within nine days.

It’s encouraging that the drug is “amenable to dosing every six months”, said Dr Rajesh Gandhi, an infectious disease physician at Massachusetts General Hospital, in Boston.

A pair of drugs

Gandhi, who is also chair-elect of the HIV Medicine Association, agreed there is a need for longer-acting HIV drugs.

The catch is that HIV is not treated with one drug alone – to keep the virus suppressed and limit the chances of it becoming resistant to medication.

So, for any twice-a-year regimen to become a reality, Gandhi explained, two long-acting drugs would have to be paired.

“So the question is, what do you partner this drug with?” he said.

Rhee said Gilead is working on such a partner. More immediately, the researchers will study the effects of lenacapavir, taken every six months, in HIV patients who’ve tried many standard drugs and are resistant to them.

Easier adherence

Other longer-acting drugs for HIV are further along – though the doses are more frequent than twice a year.

Researchers are studying a combination of two injection drugs – cabotegravir and rilpivirine – that is given monthly. The hope is to keep HIV suppressed in patients who have got the virus down to very low levels with standard oral drugs.

Meanwhile, cabotegravir is also being tested for preventing HIV in high-risk people, according to the US National Institutes of Health. In those trials, injections are given every two months.

But while infrequent doses would be convenient and – hopefully – make adherence easier, there are safety questions. If people have side effects from the drug, for example, does that mean they are stuck with them for six months?

To help avoid that, Gandhi said, studies have been using a “lead-in” phase: Patients first take oral versions of the long-acting drugs, to make sure they can tolerate them.

Still committed to finding a cure

But another concern, Gandhi said, is what could happen if patients miss or delay an injection: As levels of the drug wane in the body, the virus could come roaring back, and possibly develop resistance to the medication.

Rhee agreed that is an issue that will face all long-acting HIV medications under development.

Still, the progress toward new options is encouraging, according to Gandhi. People with HIV should know that scientists are still working on new treatments, he said – including ways to potentially cure it.

“We’re still committed to finding a cure,” Gandhi said.

Image credit: iStock

Share Button

Health24.com | Follow exercise guidelines and you’ll live longer, study says

  • According to a recent study, exercise can definitely increase one’s lifespan
  • Data indicate that only 16% of participants in the study did the recommended amount of exercise
  • The risk of death from any cause was 40% lower among those who did both sufficient muscle-strengthening and aerobic activities

Getting the recommended amount of exercise could cut your risk of early death, a new study indicates.

US government guidelines recommend at least 150 minutes of moderate-intensity or at least 75 minutes of vigorous-intensity aerobic activity a week. They also suggest adults do moderate or greater intensity muscle-strengthening exercise at least two days a week.

That effort pays off in longevity, according to the study published on 1 July in BMJ.

“Our findings support that the physical activity levels recommended in the 2018 physical activity guidelines for Americans provide important survival benefits,” researcher Bo Xi and colleagues wrote in a journal news release.

Benefits higher for vigorous exercise

“Additionally, in accordance with the guidelines, more physical activity than the minimum recommendation could provide greater health benefits,” Xi, a professor of cardiovascular epidemiology at Shandong University in China, and co-authors said.

To assess the benefits of these guidelines, the researchers analysed data from nearly 480 000 US adults, ages 18 to 85, who were followed for an average of nearly nine years.

During that time, only 16% of the participants fully met the recommended activity levels, and nearly 60 000 died.

Compared to those who didn’t meet the recommended activity levels, the risk of death from any cause was 11% lower among those who engaged in sufficient muscle-strengthening exercise. It was 29% lower among those who did sufficient aerobic exercise, and 40% lower among those who did both sufficient muscle-strengthening and aerobic activities.

The researchers also found that adults who did sufficient aerobic exercise had a lower risk of death from these specific causes – heart disease, cancer, chronic lower respiratory tract diseases, accidents and injuries, Alzheimer’s disease, and diabetes. Those who did sufficient strengthening exercises had a lower risk of death from heart disease, cancer and chronic lower respiratory tract disease.

Survival benefits were slightly higher for vigorous exercise than for light to moderate activity.

The study doesn’t establish a direct cause-and-effect relationship. Still, inactivity is a global public health issue. It’s estimated that inactivity was responsible for 6 to 10% of major chronic non-communicable diseases and 9% of early deaths worldwide in 2008.

Image credit: iStock

NEXT ON HEALTH24X

Share Button

Coronavirus: Spanish study casts doubt on herd immunity feasibility

A Lancet study estimates that around just 5% of the Spanish population has developed antibodies.

Share Button

Coronavirus: Majority testing positive have no symptoms

A survey by the Office for National Statistics looked at who had been infected in the community in England.

Share Button

Health24.com | Seizures after vaccination don’t affect kids’ development

  • Children may suffer febrile seizures after being vaccinated
  • This can be distressing for both the child and the parents
  • Australian researchers, however, found that vaccines are safe and that these seizures will not negatively affect kids’ development

Kids who have a fever-related seizure after getting a vaccine won’t have developmental and behavioural problems as a result, according to a new study.

These so-called febrile seizures do not affect children’s development whether they occur after a vaccination or not, the researchers said.

“A febrile seizure can occur following vaccination and understandably can be quite distressing to parents. It can also cause parents to lose confidence in future vaccinations,” said study author Dr Lucy Deng. She is a paediatrician at the National Center for Immunization Research and Surveillance in Sydney, Australia.

“Now, parents will be relieved to hear that having a febrile seizure following vaccination does not affect the child’s development,” Deng added.

Emerging new diseases

For the study, Deng’s team compared 62 kids who had a fever-related seizure within two weeks of a shot with 70 who had a seizure from another cause and 90 who never had a seizure. All were about two years old.

The investigators found no differences in development, thinking skills or behaviour among the three groups.

“At a time when there is a global resurgence of measles and new diseases are emerging, our findings are particularly important in reassuring parents and providers on the safety of vaccines,” Deng said in a news release from the American Academy of Neurology.

The report was published online on 1 July in the journal Neurology.

Image credit: Unsplash

NEXT ON HEALTH24X

Share Button